The global contrast media market size is expected to reach USD 10.74 billion by 2030, registering a CAGR of 7.98% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases is fueling the demand for diagnostic imaging treatments, which is propelling the market forward. Imaging studies, such as MRI, have become an important aspect of most disease diagnoses, and the widespread use of imaging technologies in healthcare has boosted the demand for contrast media globally.
Chronic diseases like cancer and diabetes are quickly becoming a major public health concern and are among the leading causes of mortality worldwide, necessitating the development of early detection techniques and effective treatment alternatives. As a result, one of the key drivers of imaging tests and contrast agents is the rising prevalence of complicated comorbidities and long-term disorders, thus boosting the market worldwide.
Due to fewer patient visits to hospitals, the COVID-19 pandemic had a detrimental influence on the global contrast media market. The number of imaging cases in several radiology departments dropped dramatically. Many countries worldwide have begun to rebuild their economy, but it will take time for contrast media utilization rates to return to pre-pandemic levels. Furthermore, with the launch of COVID-19 vaccines and the relaxation of restrictions, raw material imports and exports have begun, indicating that the market will develop at a high rate throughout the projection period.
Gather more insights about the market drivers, restrains and growth of the Global Contrast Media Market
Contrast Media Market Report Highlights
On the basis of modality, the X-ray/Computed Tomography segment held the largest market share in 2023, accounting for 69.64%. Wide acceptance and cost-efficiency of the X-ray/CT modality boost the adoption of contrast agents used for this modalityBased on product type, the iodinated contrast media segment held the largest market share in 2023, accounting for 65.37%. This is due to their excellent radio-opacity and low toxicity than other agentsBased on application, the neurological disorders segment dominated the market and held the largest revenue share around 28.59% in 2023. Diagnostic evaluation of CNS for neurological disorders boosts the adoption of MRI contrast agents, as they provide better images of neural structures than CT
Browse through Grand View Research's Medical Devices Industry Research Reports.
Synoptophore Market: The global synoptophore market was estimated at USD 256.1 million in 2024 and is projected to grow at a CAGR of 6.9% from 2025 to 2030.Ophthalmic Sutures Market: The global ophthalmic sutures market size was estimated at USD 467.3 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030.
Contrast Media Market Segmentation
Grand View Research has segmented the global contrast media market report based on modality, product, application, route of administration, end-use, and region:
Contrast Media Modality Outlook (Revenue, USD Million, 2018 - 2030)
UltrasoundMagnetic Resonance ImagingX-ray/Computed TomographyContrast Media Product Type Outlook (Revenue, USD Million, 2018 - 2030)
MicrobubbleGadolinium-BasedIodinatedBarium-BasedContrast Media Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular DisordersNeurological DisordersGastrointestinal DisordersCancerNephrological DisordersMusculoskeletal DisordersOthersContrast Media Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)
IntravenousOral RouteRectal RouteContrast Media End-use Outlook (Revenue, USD Million, 2018 - 2030)
HospitalsDiagnostic Imaging CentersOthersContrast Media Regional Outlook (Revenue, USD Million, 2018 - 2030)
North AmericaS.CanadaEuropeUKGermanyFranceItalySpainDenmarkSwedenNorwayAsia PacificJapanChinaIndiaAustraliaThailandSouth KoreaLatin AmericaBrazilMexicoArgentinaMiddle East & AfricaSouth AfricaSaudi ArabiaUAEKuwaitOrder a free sample PDF of the Contrast Media Market Intelligence Study, published by Grand View Research.
